NASDAQ
Intellipharmaceutics International Inc. (IPCIF) has a free cash flow growth of 168.40% as of Friday, May 29, 2026. This represents a 22.78% decrease compared to its 12-month average of 218.08%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.